Illumina Ventures

Portfolio Companies 2026 for Illumina Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Illumina Ventures accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $1.8B. The median disclosed raise is $86M, and the largest is Delfi Diagnostics at $400M, ahead of Encoded Therapeutics ($240M) and SonoThera ($215M).

The names that recur most often on these portfolio cap tables are Illumina Ventures (15 companies), Northpond Ventures (3 companies), Alexandria Venture Investments (3 companies), Menlo Ventures (2 companies), Osage University Partners (2 companies), GV (2 companies). By latest disclosed round, the market skews Series B (5), Series A (4), Series D (2), Series C (1).

Best funded Illumina Ventures companies

  1. Delfi Diagnostics — $400M (latest: Series B)
  2. Encoded Therapeutics — $240M (latest: Series D)
  3. SonoThera — $215M (latest: Series B)
  4. SQZ Biotech — $200M (latest: Series D)
  5. DNA Script — $112M
  6. Sherlock Biosciences — $111M (latest: Series B)
  7. Pattern Bioscience — $105M (latest: Series C)
  8. NanoCellect Biomedical — $86M (latest: Series AA)
  9. Precede Biosciences — $84M (latest: Series B)
  10. Memora Health — $81M
  11. Attovia Therapeutics — $60M (latest: Series A)
  12. Genome Medical — $60M (latest: Series B)
  13. Actym Therapeutics, Inc. — $60M (latest: Series A)
  14. Walking Fish Therapeutics — $23M (latest: Series A)
  15. Infinity Pharmaceuticals — $8M (latest: Series A)

Illumina Ventures — related firms and companies (56)

Illumina Ventures profile · All research reports